We are live on ! Find out more
MLAB icon

Mesa Laboratories
MLAB

160 hedge funds and large institutions have $833M invested in Mesa Laboratories in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 49

22% more capital invested

Capital invested by funds: $681M → $833M (+$152M)

4.22% more ownership

Funds ownership: 91% → 95.22% (+4.2%)

9% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 23

2% less funds holding

Funds holding: 163 → 160 (-3)

Holders
160
Holders Change
-3
Holders Change %
-1.84%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
64
Reduced
49
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$36.8M
2
GCM
Geneva Capital Management
Wisconsin
+$13.6M
3
CCA
Conestoga Capital Advisors
Pennsylvania
+$13.6M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.56M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.43M

Top Sellers

1
RA
Royce & Associates
New York
-$14.2M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$6.38M
3
PI
Putnam Investments
Massachusetts
-$3.29M
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$2M
5
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$145M +$1.79M +11,426 +1%
CCA
2
Conestoga Capital Advisors
Pennsylvania
$95.5M +$13.6M +86,648 +18%
Vanguard Group
3
Vanguard Group
Pennsylvania
$59.7M +$1.61M +10,266 +3%
Morgan Stanley
4
Morgan Stanley
New York
$43.8M +$36.8M +234,712 +809%
Invesco
5
Invesco
Georgia
$38.6M +$126K +801 +0.3%
RIM
6
Ranger Investment Management
Texas
$35.6M +$913K +5,829 +3%
State Street
7
State Street
Massachusetts
$34.4M -$327K -2,089 -1%
GCM
8
Geneva Capital Management
Wisconsin
$31.9M +$13.6M +87,031 +83%
RA
9
Royce & Associates
New York
$26.7M -$14.2M -90,603 -36%
Principal Financial Group
10
Principal Financial Group
Iowa
$25M +$1.87M +11,932 +9%
Kayne Anderson Rudnick Investment Management
11
Kayne Anderson Rudnick Investment Management
California
$23.9M -$277K -1,767 -1%
EAM
12
Eagle Asset Management
Florida
$17.2M +$1.58M +10,077 +11%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$15.9M +$516K +3,295 +4%
Schroder Investment Management Group
14
Schroder Investment Management Group
United Kingdom
$15.8M -$6.38M -40,733 -30%
Northern Trust
15
Northern Trust
Illinois
$14M +$3.29K +21 +0%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$13M +$6.56M +41,855 +116%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$11M +$1.99M +12,716 +24%
Ameriprise
18
Ameriprise
Minnesota
$10.9M -$54.1K -345 -0.5%
Wells Fargo
19
Wells Fargo
California
$10.2M -$429K -2,737 -4%
RJA
20
Raymond James & Associates
Florida
$9.66M +$1.83M +11,693 +25%
Comerica Bank
21
Comerica Bank
Texas
$9.27M +$814K +5,193 +11%
GT
22
Glenmede Trust
Pennsylvania
$8.51M -$1.11M -7,083 -12%
DDC
23
DF Dent & Co
Maryland
$8.49M -$496K -3,165 -6%
Citadel Advisors
24
Citadel Advisors
Florida
$8.4M +$4.43M +28,257 +127%
FAM
25
Fred Alger Management
New York
$8.18M +$940 +6 +0%
1
2 3 4 5

MLAB Hedge Fund Activity: Q4 2022 in Review

160 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2022, worth a combined $833M — up 22% from $681M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MLAB positions and 23 closed out — a net gain of 2 holders — while 64 added to existing stakes and 49 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $36.8M. The largest seller was Royce & Associates, cutting an estimated $14.2M.

  • 160 institutional investors held Mesa Laboratories (MLAB) as of Q4 2022, down from 163 in Q3 2022.
  • Funds reported $833M of Mesa Laboratories stock for Q4 2022, up 22% quarter-over-quarter.
  • 25 funds opened new Mesa Laboratories positions in Q4 2022 and 23 closed out, a net change of +2 holders.
  • The largest Mesa Laboratories buyer in Q4 2022 was Morgan Stanley, an estimated $36.8M added.
  • The largest Mesa Laboratories seller in Q4 2022 was Royce & Associates, an estimated $14.2M sold.

Based on aggregated 13F filings for Q4 2022.